These result in the release and nuclear translocation of the p65/p50 heterodimers, thereby activating downstream anti-apoptotic genes such as BCL-XL and BCL2, thus promoting tumor cell survival and tumor progression. The gene discussed is BCL2L1; the disease is neoplasm.